Pasireotide (SOM230) With or Without Everolimus in Treating Patients With Hormone Resistant, Chemotherapy Naive Prostate Cancer
Clinical trial NCT01313559 · TERMINATED
Trial details
- NCT number
- NCT01313559
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2012-09-15
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.